Agnieszka Julia Kudasiewicz-Kardaszewska

Dr. Agnieszka Julia Kudasiewicz-Kardaszewska


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2023 in Clinics in Dermatology
Verified
Journal Article
Closed access
AKAgnieszka Julia Kudasiewicz-Kardaszewska
Agnieszka Julia Kudasiewicz-Kardaszewska
JGJane M. Grant-Kels
Jane M. Grant-Kels
AGAndrzej Grzybowski
Andrzej Grzybowski

3 September 2025 in Cureus
Verified
Journal Article
Open access
PDF file
AKAgnieszka Julia Kudasiewicz-Kardaszewska
Agnieszka Julia Kudasiewicz-Kardaszewska
MOMalgorzata A. Ozimek
Malgorzata A. Ozimek
AKAleksandra Kardaszewska
Aleksandra Kardaszewska
KBKarolina Boninska
Karolina Boninska
FKFerenc Kuhn
Ferenc Kuhn
AKAgnieszka Julia Kudasiewicz-Kardaszewska
Agnieszka Julia Kudasiewicz-Kardaszewska
This article presents an overview of endophthalmitis, a severe intraocular inflammatory condition that can develop following surgery, intravitreal injections (IVIs), or ocular trauma. Endogenous cases may also arise, particularly in patients with compromised immune systems. A broad spectrum of pathogens, including bacteria, fungi, and viruses, can be involved, with some displaying high virulence. Given the rapid progression and potential for vision-threatening complications or systemic involvement such as sepsis, immediate and appropriate intervention is essential. Surgical management, especially vitrectomy, plays a central role in treatment. The Complete Early Vitrectomy for Endophthalmitis (CEVE) protocol has demonstrated high effectiveness, particularly when integrated into outpatient ophthalmic surgical practices. This review describes the protocol's practical application in such settings. In addition, it discusses preventive strategies for ocular surgery and injections, with a particular focus on the judicious use of antimicrobial agents. Incorrect antibiotic use, including unnecessary prescribing, inadequate dosing, or prolonged treatment, remains a leading contributor to the development of antimicrobial resistance and warrants critical evaluation. In summary, the CEVE approach appears to offer broad efficacy across different causes of endophthalmitis. Povidone-iodine (PI) remains the most effective agent for perioperative antisepsis. The use of prophylactic antibiotics should be confined to brief, high-potency topical therapy following intraocular procedures, including cataract surgery and phacovitrectomy. Current evidence does not support the routine use of prophylactic antibiotics after intravitreal injections due to minimal benefit and the risk of promoting resistant organisms.

19 May 2025 in Life
Verified
Journal Article
Open access
PDF file
AKAgnieszka Julia Kudasiewicz-Kardaszewska
Agnieszka Julia Kudasiewicz-Kardaszewska
MOMałgorzata Ozimek
Małgorzata Ozimek
TUTomasz Urbański
Tomasz Urbański
SCSławomir Jaroslaw Cisiecki
Sławomir Jaroslaw Cisiecki
Aim: This case report presents an unusual instance of bilateral choroidal effusion following the oral administration of acetazolamide for the treatment of pseudophakic cystoid macular edema (PCME). Case Presentation: An 87-year-old Caucasian man experienced sudden, painless vision loss in both eyes several days after beginning treatment for PCME in his left eye. He had undergone uncomplicated cataract surgery in both eyes two months earlier. The treatment regimen included oral acetazolamide (250 mg twice daily) and topical pranoprofen, a nonsteroidal anti-inflammatory drug (NSAID). One week after the initiation of acetazolamide treatment, the patient suffered a marked decline in visual acuity. Bilateral choroidal effusion was diagnosed. Prompt discontinuation of acetazolamide and initiation of topical dexamethasone (1% hourly) and atropine (1% twice daily) resulted in rapid clinical improvement. Conclusions: Carbonic anhydrase inhibitors (CAIs) such as acetazolamide, although commonly used to manage intraocular pressure, can cause choroidal effusion—a rare but potentially sight-threatening complication. Ophthalmologists should exercise caution, particularly in elderly patients, and be alert to early signs of this adverse effect. Early diagnosis and prompt management are essential to prevent permanent visual damage. To our knowledge, this is the first reported case of bilateral choroidal detachment associated with acetazolamide in the context of PCME.